Publications

From Risk Aversion to Real-World Impact: How Medtech Firms Can Harness AI

Quoted, Medtech Insight

Shareholder Joelle Wilson discusses how medical device companies are exploring AI for regulatory purposes but face barriers such as risk aversion and regulatory challenges, and how, despite significant potential benefits, many firms hesitate to fully implement AI due to unclear regulations.